Who is sponsoring NCT03402516?

NCT03402516 is sponsored by Bicetre Hospital.

What drugs are being tested in NCT03402516?

Interventions in NCT03402516: 18.5 resector, 26Fr resector.

What condition does NCT03402516 study?

NCT03402516 studies Rate of Complete Resection in a Unique Surgical Time.

Is NCT03402516 still recruiting?

NCT03402516 is currently status unknown. Last updated 27 January 2021.

Last reviewed 2021-01-27 · How we verify

NCT03402516: DIAPER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Two Bipolar Resector in Less Than 3cm Myoma Resection

Status unknown NA Last updated 27 January 2021

What this trial tests

NA trial testing 18.5 resector in Rate of Complete Resection in a Unique Surgical Time in 308 participants. Status unknown.

Timeline

1 November 2017

Primary endpoint
31 December 2021

31 March 2022

Quick facts

Lead sponsor	Bicetre Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	308
Start date	1 November 2017
Primary completion	31 December 2021
Estimated completion	31 March 2022
Sites	1 location across France

Drugs / interventions tested

18.5 resector
26Fr resector

Conditions studied

Rate of Complete Resection in a Unique Surgical Time — all drugs for Rate of Complete Resection in a Unique Surgical Time →

Sponsor

Bicetre Hospital

Who can join

18 and older, female only, with Rate of Complete Resection in a Unique Surgical Time. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hysteroscopic resection of type 0, 1 or 2 myoma is frequent. The more frequent resector used for myoma resection is 26Fr hysteroscope. Actual miniaturization of resector led to 18.5Fr resector with a potential benefit because of less dilatation. These resectors are often used but no scientific evaluation has been performed. Hypothesis of this non inferiority trial is that complete resection in a unique surgical time will be comparable with both resectors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Bicetre Hospital trials

Trials by the same sponsor.

NCT07453901 — The Multicentre Prospective Observational Study on the Management of Septic Shock · not yet recruiting
NCT06772038 — Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion · recruiting
NCT06839404 — Pharmacodynamic Analysis of the HaemOdynamic Effects of a Standard Fluid BolUS · recruiting
NCT05676723 — Thoracic Fluid Content by Bioimpedance-based Starling System · completed
NCT04870892 — Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03402516 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bicetre Hospital
Last refreshed: 27 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03402516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing